Jasper Therapeutics, Inc.
Jasper Therapeutics, Inc.
Join ActionIf you are a Jasper Therapeutics investor who suffered a loss and would like to learn more, you can provide your information below:
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Jasper Therapeutics for allegedly misleading investors about its manufacturing controls, clinical trials, and financial stability. After disclosing major product and trial issues on July 7, 2025, Jasper’s stock dropped over 55%.
If you purchased Jasper shares between November 30, 2023 and July 3, 2025, you may be eligible to recover your losses.
Lead Plaintiff Deadline: November 18, 2025
📞 Call Partner Josh Wilson at 877-247-4292 or 212-983-9330 (Ext. 1310)
💻 Or submit your information below to learn about your rights.